Md Abdus Subhan (Abdus Subhan)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 25

Top Topics

Hyaluronic Acid

Top Venues

Journal of personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Md Abdus Subhan, Vladimir P Torchilin
Advances in siRNA Drug Delivery Strategies for Targeted TNBC Therapy. Bioengineering (Basel, Switzerland) 11 (8) (2024)
Md Abdus Subhan, Vladimir P Torchilin
Advances in siRNA Drug Delivery Strategies for Targeted TNBC Therapy. Bioengineering (Basel, Switzerland) 11 (8) (2024)
Md Abdus Subhan, Vladimir P Torchilin
Advances in Targeted Therapy of Breast Cancer with Antibody-Drug Conjugate. Pharmaceutics 15 (4) (2023)
Md Abdus Subhan, Vladimir P Torchilin
Advances in Targeted Therapy of Breast Cancer with Antibody-Drug Conjugate. Pharmaceutics 15 (4) (2023)
Md Abdus Subhan, Farzana Parveen, Hassan Shah, Satya Siva Kishan Yalamarty, Janaína Artem Ataide, Valdimir P Torchilin
Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type. Cancers 15 (8) (2023)
Md Abdus Subhan, Farzana Parveen, Nina Filipczak, Satya Siva Kishan Yalamarty, Vladimir P Torchilin
Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis. Journal of personalized medicine 13 (3) (2023)
Md Abdus Subhan, Vladimir P Torchilin
Advances in Targeted Therapy of Breast Cancer with Antibody-Drug Conjugate. Pharmaceutics 15 (4) (2023)
Md Abdus Subhan, Vladimir P Torchilin
Biopolymer-Based Nanosystems for siRNA Drug Delivery to Solid Tumors including Breast Cancer. Pharmaceutics 15 (1) (2023)
Md Abdus Subhan, Vladimir P Torchilin
Biopolymer-Based Nanosystems for siRNA Drug Delivery to Solid Tumors including Breast Cancer. Pharmaceutics 15 (1) (2023)
Satya Siva Kishan Yalamarty, Nina Filipczak, Xiang Li, Md Abdus Subhan, Farzana Parveen, Janaína Artem Ataide, Bharat Ashok Rajmalani, Vladimir P Torchilin
Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM). Cancers 15 (7) (2023)
Md Abdus Subhan, Vladimir P Torchilin
Biopolymer-Based Nanosystems for siRNA Drug Delivery to Solid Tumors including Breast Cancer. Pharmaceutics 15 (1) (2023)
Md Abdus Subhan, Farzana Parveen, Nina Filipczak, Satya Siva Kishan Yalamarty, Vladimir P Torchilin
Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis. Journal of personalized medicine 13 (3) (2023)
Md Abdus Subhan, Nina Filipczak, Vladimir P Torchilin
Advances with Lipid-Based Nanosystems for siRNA Delivery to Breast Cancers. Pharmaceuticals (Basel, Switzerland) 16 (7) (2023)
Md Abdus Subhan, Farzana Parveen, Nina Filipczak, Satya Siva Kishan Yalamarty, Vladimir P Torchilin
Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis. Journal of personalized medicine 13 (3) (2023)
Md Abdus Subhan, Farzana Parveen, Hassan Shah, Satya Siva Kishan Yalamarty, Janaína Artem Ataide, Valdimir P Torchilin
Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type. Cancers 15 (8) (2023)
Md Abdus Subhan, Vladimir P Torchilin
Advances in Targeted Therapy of Breast Cancer with Antibody-Drug Conjugate. Pharmaceutics 15 (4) (2023)
Md Abdus Subhan
Advances with metal oxide-based nanoparticles as MDR metastatic breast cancer therapeutics and diagnostics. RSC advances 12 (51) (2022)
Md Abdus Subhan, Mohammed Muzibur Rahman
Recent Development in Metallic Nanoparticles for Breast Cancer Therapy and Diagnosis. Chemical record (New York, N.Y.) 22 (7) (2022)
Md Abdus Subhan, Pallab Chandra Saha, Md Anwar Hossain, Abdullah M Asiri, Md Mahmud Alam, Mohammad Al-Mamun, William Ghann, Jamal Uddin, Topu Raihan, A K Azad, Mohammed M Rahman
Photocatalytic performance, anti-bacterial activities and 3-chlorophenol sensor fabrication using MnAl 2 O 4 ·ZnAl 2 O 4 nanomaterials. Nanoscale advances 3 (20) (2021)
Md Abdus Subhan, Satya Siva Kishan Yalamarty, Nina Filipczak, Farzana Parveen, Vladimir P Torchilin
Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment. Journal of personalized medicine 11 (6) (2021)
Md Abdus Subhan, Sara Aly Attia, Vladimir P Torchilin
Targeted siRNA nanotherapeutics against breast and ovarian metastatic cancer: a comprehensive review of the literature. Nanomedicine (London, England) 17 (1) (2021)
Md Abdus Subhan, Pallab Chandra Saha, Md Anwar Hossain, Md Mahmud Alam, Abdullah Mohammed Asiri, Mohammed Muzibur Rahman, Mohammad Al-Mamun, Tanjila Parvin Rifat, Topu Raihan, A K Azad
Photocatalysis, photoinduced enhanced anti-bacterial functions and development of a selective m -tolyl hydrazine sensor based on mixed Ag·NiMn 2 O 4 nanomaterials. RSC advances 10 (51) (2020)
Faizah Saadmim, Taseen Forhad, Ahmed Sikder, William Ghann, Meser M Ali, Viji Sitther, A J Saleh Ahammad, Md Abdus Subhan, Jamal Uddin
Enhancing the Performance of Dye Sensitized Solar Cells Using Silver Nanoparticles Modified Photoanode. Molecules (Basel, Switzerland) 25 (17) (2020)
Md Abdus Subhan, Tanjila Parvin Rifat, Pallab Chandra Saha, Md Mahmud Alam, Abdullah Mohammed Asiri, Mohammed Muzibur Rahman, Sonia Akter, Topu Raihan, A K Azad, Jamal Uddin
Enhanced visible light-mediated photocatalysis, antibacterial functions and fabrication of a 3-chlorophenol sensor based on ternary Ag 2 O·SrO·CaO. RSC advances 10 (19) (2020)
Md Abdus Subhan, Pallab Chandra Saha, Shamim Ahmed Sumon, Jahir Ahmed, Abdullah Mohammed Asiri, Mohammed Muzibur Rahman, Mohammad Al-Mamun
Enhanced photocatalytic activity and ultra-sensitive benzaldehyde sensing performance of a SnO 2 ·ZnO·TiO 2 nanomaterial. RSC advances 8 (58) (2018)